blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3076975

EP3076975 - METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  11.07.2019
Database last updated on 07.10.2024
Most recent event   Tooltip30.09.2024Change: Despatch of examination report + time limit 
Applicant(s)For all designated states
Pharmacyclics LLC
1 N. Waukegan Road
North Chicago, IL 60064 / US
For all designated states
Regents Of The University Of Minnesota
200 Oak Street SE, Suite 600
Minneapolis, Minnesota 55455 / US
[2022/19]
Former [2017/35]For all designated states
Pharmacyclics LLC
995 East Arques Avenue
Sunnyvale, CA 94085 / US
For all designated states
Regents Of The University Of Minnesota
200 Oak Street SE, Suite 600
Minneapolis, Minnesota 55455 / US
Former [2016/41]For all designated states
Pharmacyclics, LLC
995 East Arques Avenue
Sunnyvale, CA 94085 / US
For all designated states
Regents Of The University Of Minnesota
200 Oak Street SE, Suite 600
Minneapolis, Minnesota 55455 / US
Inventor(s)01 / BLAZAR, Bruce, R.
4350 Sussex Road
Golden Valley, MN 55416 / US
02 / FLYNN, Ryan
15 22nd Avenue NE
Minneapolis, MN 55418 / US
 [2016/41]
Representative(s)Mathys & Squire
The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2016/41]Williams, Richard Andrew Norman
HGF Limited
140 London Wall
London EC2Y 5DN / GB
Application number, filing date14867905.302.12.2014
[2016/41]
WO2014US68177
Priority number, dateUS201361910944P02.12.2013         Original published format: US 201361910944 P
US201461973178P31.03.2014         Original published format: US 201461973178 P
[2016/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015084857
Date:11.06.2015
Language:EN
[2015/23]
Type: A1 Application with search report 
No.:EP3076975
Date:12.10.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 11.06.2015 takes the place of the publication of the European patent application.
[2016/41]
Search report(s)International search report - published on:KR11.06.2015
(Supplementary) European search report - dispatched on:EP31.03.2017
ClassificationIPC:A61K31/519, A61P37/00, A61P43/00, A61K35/28, A61K45/06
[2017/18]
CPC:
A61K31/519 (EP,IL,KR,US); A61K35/28 (EP,IL,US); A61K45/06 (EP,IL,US);
A61P11/00 (EP,IL); A61P37/00 (EP,IL); A61P37/06 (EP,IL,KR);
A61P43/00 (EP,IL); A61K2035/124 (EP,IL,US) (-)
Former IPC [2016/41]A61K31/519, A61K31/506, A61P37/00, A61P43/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/41]
Extension statesBA02.06.2016
ME02.06.2016
TitleGerman:VERFAHREN ZUR BEHANDLUNG UND PRÄVENTION VON ALLOANTIKÖRPER-GESTEUERTER CHRONISCHER TRANSPLANTAT-GEGEN-EMPFÄNGER-KRANKHEIT[2016/41]
English:METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE[2016/41]
French:MÉTHODES DE TRAITEMENT ET DE PRÉVENTION DE LA MALADIE CHRONIQUE DU GREFFON CONTRE L'HÔTE CAUSÉE PAR LES ALLOANTICORPS[2016/41]
Entry into regional phase02.06.2016National basic fee paid 
02.06.2016Search fee paid 
02.06.2016Designation fee(s) paid 
02.06.2016Examination fee paid 
Examination procedure02.06.2016Examination requested  [2016/41]
30.10.2017Amendment by applicant (claims and/or description)
15.07.2019Despatch of a communication from the examining division (Time limit: M06)
24.04.2020Reply to a communication from the examining division
26.10.2020Despatch of a communication from the examining division (Time limit: M06)
10.08.2021Reply to a communication from the examining division
04.07.2022Despatch of a communication from the examining division (Time limit: M06)
17.04.2023Reply to a communication from the examining division
02.06.2023Despatch of a communication from the examining division (Time limit: M06)
10.01.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
11.03.2024Reply to a communication from the examining division
28.05.2024Despatch of a communication from the examining division (Time limit: M06)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
11.03.2024Request for further processing filed
11.03.2024Full payment received (date of receipt of payment)
Request granted
19.03.2024Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
17.04.2023Request for further processing filed
17.04.2023Full payment received (date of receipt of payment)
Request granted
25.04.2023Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
10.08.2021Request for further processing filed
10.08.2021Full payment received (date of receipt of payment)
Request granted
19.08.2021Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
24.04.2020Request for further processing filed
24.04.2020Full payment received (date of receipt of payment)
Request granted
06.05.2020Decision despatched
Fees paidRenewal fee
08.12.2016Renewal fee patent year 03
08.12.2017Renewal fee patent year 04
10.12.2018Renewal fee patent year 05
10.12.2019Renewal fee patent year 06
09.12.2020Renewal fee patent year 07
16.12.2021Renewal fee patent year 08
09.12.2022Renewal fee patent year 09
12.12.2023Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO2015061751  (PHARMACYCLICS INC [US], et al);
International search[A]US2012071497  (BUGGY JOSEPH J [US], et al);
 [X]US8476284  (HONIGBERG LEE [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.